Dark Forest Capital Management LP Revance Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$11.52 - $20.4 $7,626 - $13,504
-662 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$12.36 - $20.31 $85,803 - $140,992
-6,942 Reduced 91.29%
662 $12,000
Q4 2021

Feb 11, 2022
BUY
$12.46 - $27.87 $78,311 - $175,162
6,285 Added 476.5%
7,604 $124,000
Q3 2021

Nov 12, 2021
BUY
$25.78 - $33.21 $34,003 - $43,803
1,319 New
1,319 $37,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email